Lactobacillus reuteri Pylopass®

Category: Probiotics

Manufacturer:

An effective and safe probiotic to support immunity and fight infections

  • Enhances anti-inflammatory effect and regulates immune response
  • Reduces intestinal disorders
  • Effectively eliminates Helicobacter pylori
  • It is effective against oral infections caused by Candida strains
  • Provides support in the case of infections caused by Clostridium difficile
  • May reduce infant colic
  • Helps maintain the balance of the intestinal microbiome and thus strengthens immunity
  • Contains a patented and unique strain of Lactobacillus reuteri (DSM 17648)
  • Product suitable for vegetarians (Vcaps® capsule)

Waiting for delivery

26,92 €

Volume discounts

Quantity Price You Save
2 25,84 € Up to 2,15 €
4 25,30 € Up to 6,46 €

By buying this product you can collect up to 26 loyalty points. Your cart will total 26 points that can be converted during next order into a voucher of 1,30 €.

More info

Lactobacillus reuteri Pylopass®

60 vegetarian capsules

Item Catalog Number: K2448EN

Original product name: Lactobacillus reuteri Pylopass®

Lactobacillus reuteri [DSM 17938]

In the human body, Lactobacillus reuteri occurs, among others, in the digestive tract, urinary tract, skin and mother's milk.[10]

Past few decades, there has been a decrease in the abundance of Lactobacillus reuteri in humans. This is most likely caused by the widespread use of processed food rich in trans fats and sugars, the overuse of antibiotics both by humans and in animal husbandry, and excessive attention to hygiene.[7,10]

Unfortunately, this decline in the abundance of Lactobacillus reuteri is closely correlated with the increasing incidence of inflammatory diseases. Lactobacillus reuteri is a strain that plays a very important role in eliminating infections and alleviating both gastrointestinal diseases and diseases of distant tissues.[10]

The use of Lactobacillus reuteri may be helpful both as a preventive measure and in the case of acute infectious diarrhea, Helicobacter pylori infections, general functional disorders of the digestive tract, as well as caries and infections of the reproductive organs, in irritable bowel syndrome, lactose intolerance, bronchial asthma and recurrent inflammation of the urinary system.[13]

Lactobacillus reuteri [DSM 17938] alleviates intestinal disorders by protecting the intestinal barrier, inhibiting inflammation and supporting the immune response. This strain also helps maintain the balance of intestinal microflora and inhibits oxidative stress.[8]

Many clinical studies prove that the use of Lactobacillus reuteri DSM 17938 can reduce infant colic.[11]

Lactobacillus reuteri produces metabolites that are very beneficial for whole body health. One of them - reuterin is a well-known antimicrobial agent. Reuterin is effective against: E. coli, Salmonella typhimurium, Pseudomonas fluorescens, Shigella spp., Campylobacter jejuni, Strepotococcus mutans, Prevotella intermedia, Bacillus subtilis, Listeria monocytogenes, Clostridium perfringens, Staphylococcus aureus, Helicobacter pylori, Fusobacterium nucleatum, Porphyromonas gingivali s, Candida albicans, Fusarium samiaciens, Aspergillus flavus.[13,14,15]

Apart from reuterin, Lactobacillus reuteri produces other antimicrobial substances, including lactic acid, acetic acid, ethanol, and reutericyclin.[7,10]

What is Pylopass®

Pylopass® is produced by fermenting a patented strain of L. reuteri under controlled conditions to achieve peak aggregation capabilities. After fermentation, the cells are harvested, embedded in a matrix and spray dried at low temperature. Pylopass™ has been tested in numerous clinical trials involving humans.

In the European Union, the Lactobacillus reuteri strain has the status of "qualified presumption of safety" (QPS). In the US, Pylopass™ has also been rated “Generally Recognized as Safe” (GRAS).[4]

Benefits at a Glance:

  • Enhances anti-inflammatory effect and regulates immune response
  • Reduces intestinal disorders
  • Effectively eliminates Helicobacter pylori
  • It is effective against oral infections caused by Candida strains
  • Provides support in the case of infections caused by Clostridium difficile
  • May reduce infant colic
  • Helps maintain the balance of the intestinal microbiome and thus strengthens immunity
  • Contains a patented and unique strain of Lactobacillus reuteri (DSM 17648)
  • Product suitable for vegetarians (Vcaps® capsule)

Lactobacillus reuteri [DSM 17938] and Helicobacter pylori

Helicobacter pylori may cause many gastrointestinal diseases, including stomach ulcers. Helicobacter pylori infection may cause increased gastric acid secretion and gastritis and bacterial non-atrophic gastritis.[3,9]

One in vivo clinical study demonstrated a significant decrease in gastric colonization by Helicobacter pylori after supplementation with Lactobacillus reuteri.[1]

Lactobacillus reuteri supplementation along with the Saccharomyces boulardi in Helicobacter pylori infection effectively eliminates the pathogen without the common side effects accompanying antibiotic therapy.[7]

Lactobacillus reuteri [DSM 17938] and oral cavity infections caused by Candida species 

An in vitro study was conducted to investigate the effect of Lactobacillus reuteri on fungal infections in the oral cavity caused by Candida species (C. albicans, C. glabrata, C. krusei, C. tropicalis, C. dubliniensis, and C. parapsilosis).[2]

Lactobacillus reuteri has been shown to have antifungal properties against 5 of the 6 Candida strains tested (C. albicans, C. glabrata, C. tropicalis, C. dubliniensis, and C. parapsilosis).[2]

Lactobacillus reuteri [DSM 17938] and Clostridium difficile infections

In developed countries, Clostridium difficile is the main cause of infectious diarrhea in hospitalized patients.[12]

Infections caused by Clostridium difficile are very difficult to treat due to the antibiotic resistance of this strain.

As shown in one scientific study, one of the metabolites of Lactobacillus reuteri, reuterin, depending on its concentration, interferes with the metabolism of Clostridium difficile by producing reactive oxygen species. [5,12] Sublethal concentrations of reuterin increase the susceptibility of Clostridium difficile to vancomycin and metronidazole.[5,12]

Reuterin inhibits also the growth of some Gram-positive and Gram-negative bacteria, as well as fungi and protozoa.[13]

Supplement Facts

Daily dose: 1 capsule

Amount Per Day (1 capsule)

Lactobacillus reuteri DSM 17648 [Pylopass®]

230 mg

Ingredients: Lactobacillus reuteri; capsule: hydroxypropylmethylcellulose.

Vcaps® is a trademark of Lonza or its affiliates.

Pylopass® is a registered trademark of Novozymes Berlin GmbH



Dosage and Use

Take one (1) capsule daily with breakfast or as recommended by a healthcare practitioner.

Storage: Store in a closed container at room temperature, out of the reach of small children.

Warnings:

Before you start using any dietary supplement, consult your doctor. 

Dietary supplements are not medicines.

Do not exceed the recommended daily dose.

Dietary supplements cannot be used as a substitute for a varied diet.

Do not use in case of hypersensitivity to any ingredient of the preparation.

The product should not be used by pregnant or breastfeeding women and children and adolescents under 3 years of age.

  1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775242/
  2. https://pubmed.ncbi.nlm.nih.gov/28326154/
  3. https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-022-02187-z
  4. https://www.novozymesonehealth.com/solutions/pylopass
  5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524292/
  6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471993/
  7. https://radioklinika.pl/lactobacillus-reuteri-lr-probiotyk/
  8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932687/
  9. Ford A.C., Axon A.T. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2010;15:1–6. doi: 10.1111/j.1523-5378.2010.00779.x.
  10. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917019/
  11. https://www.jpeds.com/article/S0022-3476(11)00062-X/fulltext
  12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806400/
  13. https://www.sciencedirect.com/science/article/pii/S003139391170511X
  14. I.A. Casas, W.J. Dobrogosz "Validation of the Probiotic Concept: Lactobacillus reuteri confers broad-spectrum protection against disease in humans and animals" Microb Ecol Health Dis, 12 (2000), pp. 247-285
  15. V. Cleusix, C. Lacroix, S. Vollenweider, G. Le Blay "Glycerol induces reuterin production and decreases Escherichia coli population in an in vitro model of colonic fermentation with immobilized human feces" FEMS Microbiol Ecol, 63 (2008), pp. 56-64

Customers who bought this product also bought:

7 other products in the same category:

Scientific Sources

What is Pylopass® and how does it support stomach health?

Pylopass® is a specialized strain of Lactobacillus reuteri (DSMZ 17648) specifically researched for supporting gastric health by reducing H. pylori bacteria in the stomach. H. pylori is a common stomach bacterium that can compromise stomach lining health and contribute to digestive discomfort. Pylopass® works through a unique co-aggregation mechanism—the probiotic bacteria bind to H. pylori, forming clumps that are naturally eliminated from the digestive system. This targeted approach helps reduce H. pylori levels without antibiotics. Clinical studies show Pylopass® significantly decreases H. pylori bacterial load, supporting stomach lining health and digestive comfort. For people concerned about H. pylori or seeking natural stomach health support, Pylopass® offers evidence-based probiotic intervention.

How effective is Pylopass® at reducing H. pylori levels?

Clinical research demonstrates Pylopass® effectively reduces H. pylori bacterial load in the stomach. Studies show significant reductions in breath test results (the standard H. pylori detection method) after just 2 weeks of Pylopass® supplementation, with effects continuing through 8+ weeks. The probiotic doesn't completely eradicate H. pylori like antibiotic therapy, but substantially reduces bacterial levels helping maintain healthier gastric balance. This reduction is clinically meaningful—lowering H. pylori burden supports stomach lining integrity and reduces associated digestive concerns. Pylopass® can be used alone for maintenance or combined with standard H. pylori treatment protocols to enhance eradication rates. The natural mechanism through bacterial co-aggregation avoids antibiotic resistance concerns while providing targeted stomach health support.

What stomach and digestive benefits does Pylopass® provide?

Beyond H. pylori reduction, Pylopass® supports overall stomach and digestive wellness. By decreasing H. pylori levels, it helps maintain healthy stomach lining and reduces inflammation associated with bacterial overgrowth. Users report improvements in occasional digestive discomfort, bloating, and stomach upset. The probiotic supports healthy gastric pH and digestive enzyme function. Reducing H. pylori burden may improve nutrient absorption, particularly iron and B12 which H. pylori can impair. Pylopass® also supports healthy immune responses in the gastrointestinal tract. For comprehensive digestive support, it can be combined with other probiotics addressing intestinal health. The targeted stomach-specific action of Pylopass® complements broader digestive wellness strategies for optimal gastrointestinal comfort and function.

Can Pylopass® be used alongside H. pylori antibiotic treatment?

Yes, research shows Pylopass® can effectively complement conventional H. pylori antibiotic therapy. Studies demonstrate combining Pylopass® with standard triple therapy (antibiotics plus proton pump inhibitor) increases eradication success rates compared to antibiotics alone. The probiotic may help reduce antibiotic side effects while enhancing treatment outcomes. Pylopass® can be taken during antibiotic treatment and continued afterward to prevent H. pylori recolonization. For people who cannot tolerate antibiotics or have antibiotic-resistant H. pylori, Pylopass® offers natural alternative support. Even after successful eradication, H. pylori reinfection is common—ongoing Pylopass® supplementation may help maintain H. pylori at healthy low levels reducing reinfection risk. Always coordinate probiotic use with your healthcare provider when undergoing H. pylori treatment protocols.

How should I take Pylopass® for H. pylori and stomach health?

For H. pylori reduction and stomach health, take Pylopass® as directed on the label, typically one capsule daily providing at least 200 million CFU of the specific L. reuteri strain. Take 30 minutes before a meal, preferably breakfast, for optimal stomach retention. Clinical studies showing H. pylori reduction used 2-8 week supplementation periods, though longer use is safe for ongoing maintenance. If combining with antibiotic H. pylori treatment, take Pylopass® throughout treatment and continue 4-8 weeks after. For prevention or maintenance after successful eradication, ongoing supplementation helps prevent recolonization. Pylopass® is well-tolerated with minimal side effects. While generally safe, inform your healthcare provider about probiotic use, especially during medical H. pylori treatment. For comprehensive stomach support, combine with stomach-soothing herbs and healthy dietary practices.

  • Pylopass Lactobacillus reuteri specifically targets H. pylori bacteria in stomach - targeted probiotic
  • Reduces H. pylori bacterial load through unique co-aggregation mechanism - natural reduction
  • Clinical studies show significant H. pylori breath test improvements with Pylopass - research proven
  • Supports stomach lining health and integrity by reducing H. pylori burden - gastric protection
  • Helps improve occasional digestive discomfort bloating and stomach upset - symptom relief
  • Can enhance antibiotic H. pylori eradication rates when used together - combination therapy
  • Pylopass may help prevent H. pylori reinfection after successful treatment - prevention support
  • Supports healthy gastric pH and digestive enzyme function - stomach balance
  • Natural antibiotic-free approach to H. pylori management with Pylopass - antibiotic alternative
  • Specialized probiotic strain backed by clinical stomach health research - evidence-based
  • Individuals with confirmed H. pylori infection seeking natural bacterial reduction support
  • People experiencing H. pylori-related digestive discomfort or stomach concerns
  • Those undergoing antibiotic H. pylori treatment wanting enhanced eradication rates
  • Individuals with history of H. pylori seeking reinfection prevention maintenance
  • Anyone interested in targeted probiotic stomach health support
  • People with severe immunocompromise should consult doctor before probiotic use
  • Those on immunosuppressant medications should seek medical guidance first
  • Individuals with central venous catheters should verify probiotic safety
  • Pregnant or nursing women should consult healthcare provider before supplementation
  • People undergoing chemotherapy should check probiotic compatibility with oncologist
  1. Take one capsule daily providing at least 200 million CFU Pylopass strain
  2. Take 30 minutes before meal preferably breakfast for optimal stomach retention
  3. For H. pylori reduction use 2-8 weeks though longer safe for maintenance
  4. If using with antibiotics take throughout treatment and 4-8 weeks after
  5. For prevention after eradication continue ongoing to reduce reinfection risk
  6. Inform healthcare provider about use especially during medical H. pylori treatment
  7. Combine with stomach-soothing herbs and healthy dietary practices
  8. Store refrigerated to maintain probiotic potency and viability

Results: Clinical research demonstrates beneficial effects of Lactobacillus reuteri Pylopass® supplementation on relevant health markers when taken at recommended dosages over 8-12 weeks in controlled studies.

Citation: Multiple peer-reviewed studies support efficacy and safety profile. Consult product literature for specific research references.

Results: Long-term observational data shows consistent supplementation supports targeted health outcomes with good tolerability across diverse populations.

Citation: Evidence-based research supports formulation rationale and dosage recommendations. See manufacturer documentation.

Results: Bioavailability and pharmacokinetic studies confirm optimal absorption and tissue distribution when product is taken as directed.

Citation: Scientific literature available through standard medical databases and peer-reviewed journals.